In vitro activity of ceftazidime–avibactam and comparators against Gram-negative bacterial isolates collected in the Asia–Pacific region as part of the INFORM program (2015–2017)

Table 1 Rates of resistant subsets among Escherichia coli and Klebsiella pneumoniae isolates collected in the Asia–Pacific region (INFORM program, 2015–2017)

Organism/region/country	Total isolates	ESBL-positive, carbapenemase-negative		Carbapenemase-positive, MBL-negative		Carbapenemase-positive, MBL-positive
Organism/region/country	N	N	%	N	%	N	%
Escherichia coli
Asia–Pacific	2218	668	30.1	4	0.2	14	0.6
Australia	402	49	12.2	0	0.0	1	0.2
Japan	167	33	19.8	0	0.0	0	0.0
South Korea	449	160	35.6	0	0.0	1	0.2
Malaysia^a	72	12	16.7	0	0.0	0	0.0
Philippines	431	142	32.9	0	0.0	4	0.9
Taiwan	340	87	25.6	1	0.3	0	0.0
Thailand	357	185	51.8	3	0.8	8	2.2
Klebsiella pneumoniae
Asia–Pacific	2082	532	25.6	39	1.9	52	2.5
Australia	381	29	7.6	1	0.3	6	1.6
Japan	155	18	11.6	0	0.0	0	0.0
South Korea	335	123	36.7	5	1.5	0	0.0
Malaysia^a	80	31	38.8	0	0.0	1	1.3
Philippines	439	147	33.5	23	5.2	19	4.3
Taiwan	334	58	17.4	1	0.3	0	0.0
Thailand	358	126	35.2	9	2.5	26	7.3

ISSN: 1476-0711